Welcome to 2026
Happy New Year and Welcome to 2026. After the break, CMG has opened its doors to the new year and is in full swing. We are excited for 2026, the year of innovation. Throughout 2025, we saw customers expand existing product ranges, launch exciting new innovations, and secure placements in new retail stores. These achievements […]
CMG Breaking News: Nicotinamide mononucleotide (NMN) now permitted in Australia
Welcome to CMG Breaking News: Nicotinamide mononucleotide (NMN) now permitted in Australia Nicotinamide mononucleotide (NMN) is now a permitted ingredient for Listed Medicines (AUST L) and Assessed Listed Medicines (AUST L(A)) in Australia. Introduction Nicotinamide mononucleotide (NMN) is a bioactive nucleotide that has amassed significant attention in recent years due to its potential as a […]
CMG Ingredient Spotlight October 2025: CETO3
Welcome to the October issue of the CMG Ingredient Spotlight! This month, we’re excited to feature CETO3®. Ingredient Spotlight: CETO3® By Dr Brad McEwen PhD, MHSc, MPH, BHSc CMG Head of Products and Innovation Fatty fish are renowned for being rich sources of the essential omega-3 fatty acids EPA (20:5 n-3) and DHA (22:6 n-3), […]
CMG Ingredient Spotlight: Discover the Power of UC-II® for Joint Health
This month, we’re excited to feature UC-II®, a cutting-edge joint health ingredient revolutionising the way we think about collagen. Backed by science and driven by innovation, UC-II® offers powerful support for mobility and flexibility, making it a standout solution in the world of joint care. Additionally, we discuss future orders and an upcoming in-person event […]
New Product Development (NPD)
New Product Development (NPD): A Landmark Year for Complementary Medicines 2025 marks a pivotal year for the complementary medicines industry, driven by robust new product development (NPD) and sustained industry growth. Currently, the Australian complementary medicines market is valued at an impressive $6.2 billion annually. Consumer engagement is at an all-time high, with approximately 75% of […]
New Product Development (NPD) for 2025
New Product Development (NPD) for 2025 By Dr Brad McEwen PhD, MHSc, MPH, BHSc CMG Head of Products and Innovation 2024 marked a significant period for the industry, characterised by substantial new product development (NPD) and overall industry growth. At present, the Australian complementary medicines industry is valued at an impressive $6.2 billion annually. There […]
Q&A with Craig Fallshaw CEO
Where do you draw your inspiration from for CMG? When I was working for my Dad, I noticed that there was a bunch of start up brands that just got zero service from big manufacturers, so I decided that would be a good niche for CMG. We try hard to be make our customer service […]
Thank you for a great year 2024
As 2024 draws to a close, we would like to take a moment to thank you for your support throughout 2024. It is appreciated. This year brought many successes and achievements for our customers. We are very excited about 2025, and we are looking forward to the amazing year ahead. 2024 has been an amazing […]
CMG 2024-2025 holiday period closures and delivery schedule
CMG 2024-2025 HOLIDAY PERIOD CLOSURES AND DELIVERY SCHEDULE CMG will be closed from Monday 23rd December 2024 and reopening on Monday 6th January 2025. During this period, all operations and deliveries will be closed. While CMG will be open on the week of the 16th of December 2024 to the 20th of December 2024, deliveries […]
Merry Christmas from the Team at CMG 2022
We would like to thank you for your support over the last 12 years and wish you the best for 2023. We look forward to continue working with you and the success of your brand. Happy New Year. 2022 was a big year for CMG, its customers, and the industry. We fully moved into our […]